University Of New Mexico

University Of New Mexico Health Sciences Center, the clinical and research division of the state's flagship minority-serving research university, operates as a prime recipient for federal contracts and grants delivering specialized medical services, clinical care, biomedical research, and expert testimony to federal agencies across healthcare, defense, and law enforcement. The institution is a state-controlled, tax-exempt educational entity headquartered in Albuquerque, New Mexico, operating without SBA set-aside designations and competing predominantly full-and-open.

The Health Sciences Center's federal award footprint spans 1,266 awards (81% prime, 19% sub-awards) valued at $1.15 billion in combined potential, with $2.27 billion in combined obligations. Over the past five years, activity has declined from 113 awards in 2024 to just four in the partial 2027 data snapshot, signaling either a major shift in reporting or a recent contraction in new awards. The institution serves 114 distinct federal agencies, with extreme concentration in National Cancer Institute funding: the NCI alone anchors 91 awards carrying $834.2 million in combined potential value (73% of the institution's entire portfolio), followed distantly by Veterans Integrated Service Network 22 (92 awards, $99.5 million). The Indian Health Service represents 170 awards by count but only $20.7 million by dollars—a high-volume, low-dollar customer profile driven by specialized clinical services.

The capability portfolio is tightly aligned with the institution's medical center mission. The Health Sciences Center delivers forensic pathology and autopsy services (exemplified by a $875 thousand definitive contract with the Southwest Regional Office for forensic services through 2031 and a $3.35 million telebehavioral health program through the Indian Health Service); radiology interpretation and resident training to the VA through multiple single-award indefinite-delivery contracts (ceiling values $2.8–$4.7 million); expert pathology and witness testimony to the U.S. Attorney's Offices (recurring purchase orders in the $10 thousand–$30 thousand range); vascular surgeon services and graduate medical education support to the VA (definitive contracts ranging $850 thousand–$2.8 million); and biomedical research spanning oncology, neuroscience, immunology, environmental health, and cardiovascular disease across National Institutes of Health programs. Recent representative prime work includes a $5.96 million Defense Health Agency project on precision phenotyping of behavioral risk and electromagnetic/psychedelic therapies (with four named sub-awardees: Georgia State University, Washington University, Biomedical Research Institute of New Mexico, and Lovelace Biomedical Research Institute); a $600 thousand SAMHSA grant for trauma-informed care training and technical assistance (TRIBES 2 program) serving American Indian/Alaska Native populations; and numerous R01 and R24 project grants from NIH institutes funding investigator-initiated basic and translational research.

Vehicle holdings reflect the institution's primary-care and research role. The Health Sciences Center places task orders under five top parent IDCs: a $1.2 million ceiling HHS Indian Health Service IDC (37 task orders), a $634 thousand HHS IHS IDC (30 task orders), and three additional HHS IHS IDCs each carrying 10–16 task orders with ceilings ranging $527 thousand–$725 thousand. A single-award VA indefinite-delivery contract for radiology interpretation and resident training services carries multiple delivery orders totaling $3.8–$4.7 million ceiling value. The institution does not hold a position on government-wide GWACs; task order work is concentrated on agency-specific and program-specific IDCs.

SCI-reported federal service contract invoicing totaled $32.6 million across FY2022–FY2025 ($8.6 million in FY2022, peaking at $9.7 million in FY2023, dipping to $4.7 million in FY2024, then recovering to $9.7 million in FY2025). SCI-captured workforce on prime contracts ranged from 17.4 FTEs in FY2024 to 40.5 FTEs in FY2023, averaging roughly 30 FTEs. Government-paid rates on SCI-reportable service contracts show wide variance reflecting the institution's clinical-to-research mix: median around $125.71/hr, with senior research and expert labor pricing through $296.72/hr and entry-level support services around $64.65/hr. Across SCI-reportable prime contracts, subcontractors accounted for an average of 1% of total contractor hours, with six named subs reported across the portfolio—indicating the Health Sciences Center primarily self-performs and builds its own delivery teams rather than relying on subcontractor networks.

As a subcontractor, the institution delivers clinical trial coordination and data management services to the University of Pittsburgh (low-titer group O whole blood and tranexamic acid resuscitation trial, multiple sub-awards across 2024–2025), research support in genomics and pathology to University of Washington and Washington University, and clinical site management to Columbia University, Mayo Clinic, and other research consortia. In its sub-recipient role on federal grants, the Health Sciences Center participates in multisite research networks managed by entities including the University of Arkansas (ECHO IDeA States Pediatric Clinical Trials Network Data Coordinating Center), Drexel University (ComPASS community capacity building), and RAND Corporation (adaptive interventions for opioid use disorder and PTSD).

Federal grant work dominates by dollar magnitude. The institution is a major recipient of R01 project grants from National Institute of General Medical Sciences (exemplified by a $517 thousand award for selective autophagy mediated by TRIM proteins, a $700 thousand award on neurophysiological genetics of binge drinking, and a $2.09 million award on coronavirus RNA capping and the methionine cycle), National Cancer Institute (including a $5.6 million endometrial cancer hormone therapy multi-institutional P01 as a sub-recipient site), National Institute on Alcohol Abuse and Alcoholism (prenatal alcohol exposure effects on cognitive control, fetal alcohol spectrum disorder neurogenesis), National Institute of Allergy and Infectious Diseases (environmental trichloroethylene immunotoxicology, CD4 T cell survival in inflammatory disease), National Institute of Environmental Health Sciences (micro/nanoplastics in the brain, placental transport, and colorectal cancer; wildfire smoke and neuroinflammation), and Defense Health Agency (precision phenotyping of suicide risk, ovarian cancer therapy targeting Notch pathways, cystic kidneys in tuberous sclerosis). Non-NIH grant recipients include SAMHSA (telebehavioral health, opioid withdrawal syndrome training, SBIRT statewide implementation), the Indian Health Service (family medicine physician services at Zuni Service Unit), and the Bureau of Justice Assistance (medical examiner accreditation workload stabilization). The institution acts as prime recipient on the vast majority of its grant portfolio and as a sub-recipient when contributing specialized research or clinical expertise to larger consortia.

Recompete exposure in the next 24 months includes 109 awards with combined potential value of $34.4 million—a moderate recompete cliff concentrated in smaller grants and service contracts rather than anchor funding.